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OBJECTIVES We sought to determine whether the stringent stress test criteria for crossover to cardiac
catheterization in the conservative arm of the Fast Revascularization During Instability in
Coronary Artery Disease (FRISC-II) trial subjected this strategy to a disadvantage by failing
to identify patients with surgical coronary artery disease (CAD).
BACKGROUND In FRISC-II, an invasive strategy provided superior outcomes compared with a conservative
strategy for patients with acute coronary syndromes. However, compared with the stress test
criteria for crossover to catheterization in the Veterans Affairs Non–Q-Wave Infarction
Strategies in Hospital (VANQWISH) trial, the FRISC-II criteria were more restrictive and
did not use nuclear imaging or pharmacologic stress testing.
METHODS We analyzed the conservative arm of VANQWISH to identify the prevalence of surgical
CAD in those patients who met the VANQWISH, but not FRISC-II, criteria for
catheterization.
RESULTS Of 385 VANQWISH patients, 90 (23%) met the FRISC-II criteria for catheterization.
Another 98 patients (25%) met only VANQWISH stress test criteria (60 patients by exercise
and 38 by pharmacologic nuclear stress testing). Among subjects who underwent predischarge
angiography, those meeting only VANQWISH stress test criteria had a high prevalence of
surgical CAD (51%), comparable to patients who met FRISC-II criteria (54%, p  0.805).
CONCLUSIONS The overly stringent risk stratification protocol for conservative-arm patients in FRISC-II
could have failed to identify almost as many patients with surgical CAD as it identified. A
lower threshold for catheterization in the FRISC-II conservative patients might have
improved their outcomes and therefore diminished the putative benefit of an invasive
strategy. (J Am Coll Cardiol 2002;39:1601–7) © 2002 by the American College of
Cardiology Foundation
The Fast Revascularization During Instability in Coronary
Artery Disease (FRISC-II) trial (1,2) showed significantly
fewer deaths or nonfatal myocardial infarctions (MIs) at one
year for those patients receiving early cardiac catheterization
(invasive strategy), compared with those who underwent
medical stabilization followed by stress testing to identify
high-risk candidates for cardiac catheterization (conserva-
tive strategy). This outcome differed from the findings of
the Veterans Affairs Non–Q-Wave Infarction Strategies in
Hospital (VANQWISH) trial (3), which showed fewer
deaths or nonfatal MIs for patients with non–Q-wave MI
randomized to a conservative strategy versus an invasive
strategy at 12 months, and no significant difference in
strategies by an average of 23 months. The favorable
outcomes of the invasive strategy in FRISC-II have been
attributed to a distinct advantage of an invasive approach,
especially in the era of stents, glycoprotein IIb/IIIa inhibi-
tors and low molecular weight heparin. However, the
one-year mortality benefit of the invasive strategy in the
FRISC-II trial has not yet been substantiated by any other
trial, including the recent Treat Angina with Aggrastat and
Determine Cost of Therapy with an Invasive or Conserva-
tive Strategy-Thrombolysis In Myocardial Infarction-18
(TACTICS-TIMI-18) trial (4), which, to date, has re-
ported only a six-month advantage of an invasive strategy
for cardiovascular outcomes, but not specifically for mortal-
ity. These discrepancies, together with the relatively low
rates of crossover to early cardiac catheterization in the
conservative arm of FRISC-II (10% by 7 days) (1,2)
compared with VANQWISH (23% by discharge, which
occurred by 8.2 days on average) (3) and TACTICS-
TIMI-18 (51% by discharge) (4), raise the possibility that
the rigorous stress test criteria used in FRISC-II compro-
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mised sensitivity in identifying high-risk patients in the
conservative strategy who would have benefited from cardiac
catheterization.
It is essential to understand how a conservative strategy is
defined in any trial. A strategy that is too conservative might
put patients at a disadvantage, not because the invasive
approach is superior, but because the conservative strategy is
suboptimal. The conservative arm in both FRISC-II and
VANQWISH allowed for crossover to cardiac catheteriza-
tion in patients with refractory postinfarction angina with
electrocardiographic (ECG) changes (postinfarction angi-
na). However, the stress test criteria for crossover to cardiac
catheterization in the conservative arm of FRISC-II were
more strict compared with the criteria in VANQWISH and
TACTICS-TIMI-18. In FRISC-II, exercise stress test
(EST) criteria required3 mm ST-segment depression (2).
Furthermore, nuclear imaging and pharmacologic stress
testing were not used. Therefore, the conservative strategy
of FRISC-II may have been disadvantaged by its failure to
identify a large number of patients with surgical coronary
artery disease (CAD), thus exaggerating the purported
benefit of the FRISC-II invasive strategy.
The primary aim of this study was to determine the
prevalence of surgical CAD among VANQWISH patients
who met VANQWISH stress test criteria for crossover to
cardiac catheterization but who would not have met
FRISC-II criteria.
METHODS
Study source. Only patients in the VANQWISH trial
were used in these analyses. In VANQWISH, 920 patients
admitted with non–Q-wave MI were randomized to one of
two management strategies: an invasive arm, in which
patients underwent coronary angiography before discharge,
or a conservative arm, in which patients were selected to
receive cardiac catheterization based on their failure to be
stabilized medically or a subsequent high-risk stress test
result. Details of the study protocol have been published
previously (3).
Stress test data. Patients in the conservative arm of VAN-
QWISH who were stabilized medically underwent a pre-
discharge, symptom-limited treadmill EST using the stan-
dard Bruce protocol with planar thallium scintigraphy, or
thallium scintigraphy with single photon emission com-
puted tomography. Patients unable to exercise to a level of
five metabolic equivalents (METs) received intravenous
dipyridamole with perfusion scintigraphy. There were two
EST criteria for patients to crossover to cardiac catheteriza-
tion: 1) ST-segment depression of 2 mm on an ECG
recorded during peak exercise or 2) redistribution defects in
two or more vascular regions on thallium scintigraphy, or
one redistribution defect with increased thallium uptake by
the lung (high-risk nuclear perfusion abnormalities).
For patients in the conservative arm of FRISC-II who
were stabilized medically, the stress testing criteria varied
from those for VANQWISH (2). Patients in FRISC-II
underwent predischarge bicycle stress testing and crossed
over to cardiac catheterization only for one or more of the
following four criteria: 1) ST-segment depression 3 mm;
2) limiting chest pain associated with decrease in blood
pressure or a low maximum work load (90 W in men or
70 W in women); 3) ST-segment elevation in leads
without pre-existing Q-waves; or 4) T-wave inversion on
stress testing.
Study population. We identified patients in the conserva-
tive arm of the VANQWISH trial on the basis of whether
they would have qualified for crossover to cardiac catheter-
ization by postinfarction angina or FRISC-II EST criteria
(FRISC-II-Criteria patients), versus only VANQWISH
EST criteria (VANQWISH-EST-Criteria patients) (Fig.
1). Thus the VANQWISH-EST-Criteria group included
patients who did not have postinfarction angina but who
had 2 and 3 mm ST-segment depression alone or
2 mm ST-segment depression with high-risk nuclear
perfusion abnormalities. Patients with a history of coronary
artery bypass graft surgery (CABG) before enrollment were
excluded because of the difficulty in classifying the indica-
tion for repeat CABG in these patients and because they
were excluded from FRISC-II.
Patients who underwent dipyridamole myocardial perfu-
sion imaging (D-MPI) and had high-risk nuclear perfusion
abnormalities were analyzed separately (High-Risk D-MPI
patients), as it is not known if these patients would have
been able to perform adequately on a bicycle stress test or
what the results of the test might have been.
The FRISC-II-Criteria group included those with
postinfarction angina or at least one of the FRISC-II stress
Abbreviations and Acronyms
ACC/AHA  American College of
Cardiology/American Heart
Association
CABG  coronary artery bypass graft
surgery
CAD  coronary artery disease
D-MPI  dipyridamole myocardial
perfusion imaging
ECG  electrocardiographic/
electrocardiogram
EST  exercise stress test/exercise stress
testing
FRISC-II  Fast Revascularization During
Instability in Coronary Artery
Disease
METs  metabolic equivalents
MI  myocardial infarction
TACTICS-TIMI-18  Treat Angina with Aggrastat
and Determine Cost of Therapy
With an Invasive or
Conservative Strategy-
Thrombolysis In Myocardial
Infarction-18
VANQWISH  Veterans Affairs Non–Q-Wave
Infarction Strategies in Hospital
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test criteria for coronary angiography. Patients who devel-
oped T-wave inversions during EST were not identified in
the VANQWISH database, and therefore could not be
included in the FRISC-II-Criteria group. A decrease in
blood pressure with EST was not quantified in the
FRISC-II study. In our analysis we used a systolic blood
pressure 90 mm Hg during peak exercise or a systolic
blood pressure during peak exercise that dropped by 10
mm Hg compared with the systolic blood pressure during a
warm-up phase, as defined in VANQWISH (3). In
FRISC-II, patients who achieved 90 W (70 W for
women) during bicycle EST and who had angina qualified
for cardiac catheterization. Because patients in the VAN-
QWISH trial underwent treadmill EST in which exercise
capacity was measured in METs, the thresholds for low
workload in watts were converted to METs (5).
Outcomes. The primary outcome was the number of
patients from each comparison group who had surgical
CAD, defined as a Class I indication for CABG by the
American College of Cardiology/American Heart Associa-
tion (ACC/AHA) guidelines for CABG (6). We chose
surgical CAD as the primary end point, as patients with this
finding would be the most likely to benefit from revascu-
larization. Additional outcomes analyzed were clinical
events (all-cause death [death], cardiac death, nonfatal MI
and a composite end point of death or nonfatal MI).
Analysis of angiography results was performed only for
patients who underwent catheterization before discharge, to
avoid the potential bias of including later catheterization
results obtained because of progression of CAD or new
acute coronary events.
Statistical analysis. Continuous variables were compared
with t tests, and categorical variables with chi-square (two-
sided) and Fisher’s exact (two-tailed), as appropriate. Odds
ratios were derived for all comparisons and exact confidence
intervals were used when required. Because the goal of the
study was to compare angiographic characteristics by stress
test results in a group of patients without other clinical
indications for catheterization (regardless of other markers
of coronary disease) and because of the limited number of
primary outcome events, we limited our analyses to univar-
iate comparisons. We used STATCALC (EpiInfo, Centers
for Disease Control and Prevention, Atlanta, Georgia) and
SPSS version 10.0 (SPSS, Inc., Chicago, Illinois) to per-
form the statistical analyses.
RESULTS
Patients. Out of 458 conservative-arm patients in VAN-
QWISH, 73 were excluded on the basis of prior CABG,
Figure 1. Study design. *There were 458 patients in the conservative arm of VANQWISH; 73 with prior coronary artery bypass graft surgery were excluded
from our study. †Eighty-seven of these patients also met VANQWISH criteria for cath; three did not (two patients had ST-segment elevation on exercise
stress testing, and one experienced angina at low workload). Cath  cardiac catheterization; D-MPI  dipyridamole myocardial perfusion imaging;
FRISC-II Fast Revascularization During Instability in Coronary Artery Disease trial; ST2 ST-segment depression; VANQWISH Veterans Affairs
Non–Q-Wave Infarction Strategies in Hospital trial.
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leaving 385 patients. Of the 385 patients, 222 (58%) in the
conservative group of VANQWISH underwent predis-
charge EST, and 125 (32%) underwent D-MPI. The
distribution of the number of patients meeting each crite-
rion for crossover to cardiac catheterization are given in
Figure 1. Sixty of 385 patients (16%) met VANQWISH
EST criteria for cardiac catheterization: 20 by exercise ECG
findings with or without nuclear perfusion criteria, and 40
by nuclear perfusion criteria alone. Of these 60 patients, 21
actually received predischarge coronary angiography. An
additional 38 patients (10%) qualified for cardiac catheter-
ization by high-risk D-MPI, of whom 14 received predis-
charge coronary angiography. Ninety patients (23%) met
FRISC-II criteria: 70 with postinfarction angina and 20
with abnormal stress test results. Of these 90 FRISC-II-
Criteria patients, 48 received predischarge coronary angiog-
raphy.
As noted in Figure 1, not all patients who met VAN-
QWISH EST criteria actually underwent coronary angiog-
raphy before discharge. Although not all the reasons for this
are clear, patients who were referred for predischarge cardiac
catheterization were more likely to have a family history of
CAD (62% vs. 33%, p  0.033) and a lower ejection
fraction (42 12% vs. 53 11%, p 0.001). Similarly, not
all subjects meeting FRISC-II criteria received angiography.
However, there were no significant differences in baseline
clinical characteristics between the patients in this group
who did and did not undergo predischarge angiography.
Baseline characteristics are shown for each of the three
comparison groups (Table 1). There were no significant
differences between FRISC-II-Criteria patients and
VANQWISH-EST-Criteria patients. High-Risk D-MPI
patients were older and were more likely to have diabetes
than patients in the other two groups (p  0.05 for these
comparisons).
Coronary angiography results. Coronary angiographic re-
sults and the primary outcome (Class I indication for
CABG) are shown in Table 2. Patients in the VANQWISH-
EST-Criteria group demonstrated a high prevalence of
surgical CAD (12 of 21 patients, or 57%), as did High-Risk
D-MPI patients (6 of 14 patients, or 43%). Both of these
outcomes were similar to the prevalence of surgical CAD in
VANQWISH patients meeting the FRISC-II criteria (26
of 48 patients, or 54%, Table 2, p 0.4). When the analysis
was repeated for only those 10 FRISC-II-Criteria patients
who met FRISC-II stress test criteria (excluding the 38
Table 1. Baseline Clinical Characteristics of the VANQWISH Patients in the Conservative Arm
Who Qualified for Cardiac Catheterization According to Comparison Group*†
Characteristic
FRISC-II-
Criteria
(n  90)
VANQWISH-EST-
Criteria
(n  60)
High-Risk
D-MPI
(n  38)
Clinical characteristics (no. [%], except where
noted otherwise)
Age (yrs) 61  10‡ 58  10§ 66  10‡§
Male 85 (94) 60 (100) 37 (97)
Smoking
Never smoked 15 (17) 7 (12) 5 (13)
Prior smoker 38 (42) 17 (28) 16 (42)
Current smoker 37 (41) 36 (60) 17 (45)
Family history of CAD 35 (39) 26 (43)§ 9 (24)§
Hypertension 47 (52) 26 (43)§ 25 (66)§
High cholesterol level 13 (14) 6 (10) 7 (18)
Diabetes mellitus 24 (27)‡ 8 (13)§ 17 (45)‡§
Prior MI 34 (38) 19 (32) 19 (50)
Cardiac disease other than CAD 7 (8) 7 (12) 6 (16)
Peripheral vascular disease 17 (19) 7 (12) 10 (26)
Neurologic disorder 9 (10) 6 (10) 8 (21)
Angina in 3 wk before randomization 45 (50) 26 (43) 17 (45)
PCI 3 months before randomization 10 (11) 2 (3) 3 (8)
Baseline ejection fraction (%) 49  13 49  13 46  14
Medications 1 wk before randomization
Nitrates 23 (26) 13 (22) 14 (37)
Beta-blocker 14 (16)‡ 11 (18) 13 (34)‡
Calcium channel blocker 29 (32) 14 (23) 13 (34)
Aspirin 34 (38) 20 (33) 18 (47)
Lipid-lowering drug 9 (10) 3 (5) 5 (13)
ACE inhibitor 15 (17)‡ 12 (20) 13 (34)‡
Diuretics 12 (13)‡ 9 (15) 11 (29)‡
Digitalis 7 (8) 7 (12) 2 (5)
*Plus-minus values are means  SD. †p  0.05 for all baseline characteristics comparing VANQWISH-EST-Criteria patients
to FRISC-II-Criteria patients. ‡p  0.05 comparing High-Risk D-MPI patients to FRISC-II-Criteria patients. §p  0.05
comparing High-Risk D-MPI patients to VANQWISH-EST-Criteria patients.
ACE  angiotensin converting enzyme; CAD  coronary artery disease; D-MPI  dipyridamole myocardial perfusion
imaging; MI  myocardial infarction; PCI  percutaneous coronary intervention.
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patients with postinfarction angina), 8 (80%) had surgical
CAD (p values for all comparisons 0.1). Of the 12
patients meeting VANQWISH EST criteria who had
surgical CAD, 5 met VANQWISH ECG criteria of
2 mm ST-segment depression (with or without abnormal
nuclear perfusion imaging), and 7 had only high-risk nu-
clear findings (with 2 mm ST-segment depression on
EST).
Revascularization. We sought to determine whether the
less stringent stress test criteria in VANQWISH translated
not only to identifying more patients with surgical CAD,
but also to a comparable surgical revascularization rate of
these patients. The FRISC-II-Criteria patients had the
highest rate of predischarge CABG among the three
groups, although none of the differences were statistically
significant (all p values 0.095; Table 2). Repeat analysis
including only FRISC-II-Criteria patients with abnormal
EST results (without postinfarction angina) also showed no
statistically significant differences (all p values 0.1)
Clinical events at 12 months. Patients in the FRISC-II-
Criteria group had the highest overall one-year event rates
(Table 3). These event rates in the FRISC-II Criteria
patients were higher for all outcomes when compared with
the rates in patients meeting the VANQWISH EST
criteria and were statistically significant for nonfatal MI
(p  0.001) and combined events (p  0.001).
The all-cause mortality rate of the FRISC-II-Criteria
patients was less than that of patients with high-risk
D-MPI, although this was not statistically significant (p 
0.14). On the other hand, FRISC-II-Criteria patients had a
higher nonfatal MI rate (p  0.008). There was no
significant difference in overall event rate between these two
groups (p  0.165).
Among FRISC-II-Criteria patients, the majority of com-
bined events (27 of 30) occurred in patients with postin-
farction angina; only 3 of 30 events occurred in patients with
abnormal stress test results.
DISCUSSION
Study results and significance. Our findings demonstrate
that a substantial number of patients in VANQWISH who
did not meet FRISC-II criteria for undergoing cardiac
catheterization, but who met the VANQWISH EST cri-
teria, had surgical CAD. Similarly, those with high-risk
D-MPI had a high prevalence of surgical CAD. This raises
the possibility that the strict ECG stress test criteria and the
lack of pharmacologic stress testing or nuclear imaging in
FRISC-II resulted in an overly low-sensitivity risk stratifi-
cation tool, which might have partly accounted for the
superior outcomes of the invasive strategy in FRISC-II.
Although the FRISC-II criteria were not as sensitive in
identifying the anatomical presence of surgical CAD in
VANQWISH patients, the criteria did identify, as ex-
pected, the patients at the highest risk of the combined end
point of death or nonfatal MI. This is not surprising, given
that the most clinically high-risk patients (postinfarction
angina) were included in this group. However, when these
patients were excluded, there were no differences in clinical
event rates between FRISC-II-Criteria patients (with only
abnormal EST results) and either VANQWISH-EST-
Criteria patients or High-Risk D-MPI patients, although
the number of subjects was very small. Thus, the FRISC-II
EST criteria may have failed to identify both a large
proportion of patients with surgical CAD and a significant
number with subsequent adverse events.
Degree of ST-segment depression during EST. Twelve
of the 21 (57%) patients in VANQWISH with 3 mm
Table 2. Coronary Angiography Results of Patients Who
Underwent Angiography Before Discharge
Characteristic
FRISC-II-
Criteria
VANQWISH-
EST-Criteria
High-Risk
D-MPI
Number of patients 90 60 38
Number of patients
undergoing angiography
before discharge
48 21 14
Angiography findings—no. (%)*
No significant CAD 1 (2) 1 (5) 0 (0)
Single-vessel disease 12 (25) 5 (24) 4 (29)
Two-vessel disease 9 (19) 4 (19) 4 (29)
Three-vessel disease 20 (42) 9 (43) 4 (29)
Left main disease ( one-to-
three vessel CAD)
5 (10) 2 (10) 2 (14)
Class I indication for CABG
by class—no. (%)†‡
26 (54) 12 (57) 6 (43)
CABG before discharge—
no. (%)§
19 (40) 4 (19) 3 (21)
*One patient from the FRISC-II-Criteria group is missing angiography results.
†FRISC-II-Criteria patients versus VANQWISH-EST-Criteria patients: p 0.819;
Odds ratio (95% confidence intervals)  0.89 (0.28 to 2.81). ‡FRISC-II-Criteria
patients versus High-Risk D-MPI patients: p0.456. Odds ratio (95% confidence
intervals) 1.58 (0.41 to 6.17). §p values0.095 for all comparisons for patients who
underwent CABG before discharge.
CABG  coronary artery bypass graft surgery; CAD  coronary artery disease;
D-MPI  dipyridamole myocardial perfusion imaging.
Table 3. Clinical Outcomes of the Comparison Groups at 12 Months After Randomization
Clinical Outcome
No. (%)
FRISC-II-
Criteria
(n  90)
VANQWISH-
EST-Criteria
(n  60)
High-Risk
D-MPI
(n  38)
Met None of the Cardiac
Catheterization Criteria
(n  197)
Death 8 (9) 2 (3) 7 (18) 11 (6)
Cardiac death 5 (6) 1 (2) 4 (11) 4 (2)
Nonfatal MI 23 (26) 3 (5) 2 (5) 17 (9)
Combined events 30 (33) 4 (7) 8 (21) 23 (12)
See text for p values.
D-MPI  dipyridamole myocardial perfusion imaging; MI  myocardial infarction.
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ST-segment depression who qualified for crossover to car-
diac catheterization by the VANQWISH EST criteria were
found to have surgical CAD. The use of less stringent ECG
criteria is in accord with current guidelines from the
ACC/AHA, which state that ST-segment depression1 mm
during EST is a valid predictor of adverse outcome in the
postinfarction population (7). Prior studies have demon-
strated that 1 mm ST-segment depression on stress
testing after an acute coronary event is more sensitive for
detecting three-vessel or left main CAD or for predicting
subsequent cardiac events, compared with2 mm or3 mm
ST-segment depression (8,9).
Incremental benefit of radionuclide imaging. In our
analysis, more than half of the VANQWISH-EST-Criteria
patients with a Class I indication for CABG (7 of 12) were
patients with 2 mm ST-segment depression but an
abnormal thallium scan, thus supporting the important role
of radionuclide imaging in the prognostication of postin-
farction survivors. The incremental benefit of nuclear scin-
tigraphy over exercise ECG alone in detecting multivessel
CAD and predicting cardiac events (particularly for patients
with resting ECG abnormalities) has been previously dem-
onstrated (10,11).
Prognostic utility of pharmacologic stress testing. We
found that 32% of patients in the conservative group of
VANQWISH required pharmacologic stress testing. This
is consistent with other estimates indicating that approxi-
mately 30% of the postinfarction population are unable to
perform an exercise stress test (12). Numerous studies have
shown these patients to be at higher risk for cardiac events,
justifying further risk stratification with pharmacologic
stress testing (11,12). In VANQWISH, although patients
with a high-risk D-MPI had a lower rate of nonfatal MI,
they had a non-significantly higher mortality rate and a
comparably high combined end point rate compared with
the FRISC-II-Criteria patients. The results that exercise
testing would yield in this group of patients are unknown,
but it is reasonable to postulate that many of them would
not be able to exercise sufficiently to identify inducible
ischemia.
Comparison with the TACTICS-TIMI-18 trial. In the
TACTICS-TIMI-18 trial (4), 2,220 patients with non-ST-
segment elevation MI or unstable angina were randomized
to invasive and conservative strategies. Stress test criteria for
crossover to cardiac catheterization in the conservative arm
included 2 mm ST-segment depression on EST (1 mm
if associated with angina), as well as radionuclide or echo-
cardiographic imaging and pharmacologic stress testing in
appropriate patients. Fifty-one percent of the conservative
arm patients underwent in-hospital coronary angiography, a
much larger percentage than in both FRISC-II (10% by
seven days) (1,2) and VANQWISH (23% by discharge) (3).
Despite this, the study demonstrated a benefit of an invasive
strategy. However, this benefit was predominantly in the
high-risk patient subgroups and primarily for the outcome
of MI. This latter finding is important because tirofiban was
administered in 94% of the interventional procedures in the
invasive arm, but only 59% of the procedures in the
conservative arm. There was no significant mortality differ-
ence detected at six months between the two strategies in
this study, although the study was not powered to detect a
mortality difference, and longer-term follow-up is not yet
available.
Study limitations. Because of its small sample size, our
study may have failed to identify small but significant
differences for surgical CAD among comparison groups.
Nonetheless, we have established that a large number of the
VANQWISH conservative-arm patients with surgical
CAD would not have been identified had FRISC-II criteria
been used, regardless of whether this difference was statis-
tically significant. The clinical outcome comparisons are also
limited by the sample size and inability to perform multi-
variable adjustment.
T-wave inversions on exercise ECG was a criterion for
angiography in FRISC-II (2), but this variable was not
recorded in the VANQWISH trial. Hence, the number of
patients not meeting the FRISC-II stress test criteria may
have been overestimated. However, we found no studies
that support that T-wave inversions on exercise ECG, a
nonspecific finding (7,8), is useful in the risk stratification of
patients following acute coronary syndromes.
Our analysis of coronary anatomy includes only 35 of 98
(36%) of the patients who met the VANQWISH criteria or
D-MPI criteria for crossover to cardiac catheterization, and
48 of 90 (53%) of the patients meeting FRISC-II criteria;
the remaining patients did not receive cardiac catheteriza-
tion despite qualifying. Potential reasons for this include
perceived differences in comorbid conditions among pa-
tients or differences in patient and physician preference,
although such reasons were not documented in VAN-
QWISH. Therefore, we could not assess the true sensitivity
and specificity of the VANQWISH criteria for identifying
significant CAD. However, even if none of the patients
excluded had surgical disease, the prevalence of surgical
disease would still be relatively high in both VANQWISH-
EST-Criteria patients (12 of 60, or 20%) and High-Risk
D-MPI patients (6 of 38, or 16%).
Because not all patients underwent cardiac catheteriza-
tion, it is also possible that referral bias skewed our results.
However, there were no differences with respect to clinical
characteristics between those who did and did not undergo
catheterization in the FRISC-II group, and the only differ-
ences in the VANQWISH-EST-Criteria patients who
underwent predischarge cardiac catheterization were a
higher prevalence of family history of CAD and a lower
ejection fraction. It is possible that these differences in-
creased the degree of coronary disease in the group who
underwent catheterization.
Despite the adoption of more sensitive risk stratification
techniques in VANQWISH, the one-year death or nonfatal
MI rate in the conservative arm of VANQWISH (18.6%)
(3) was higher than in FRISC-II (14.1%) (1). Although this
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observation does not support our hypothesis, extreme cau-
tion must be used in comparing results across trials. This
discrepancy more likely reflects other differences between
the VANQWISH and FRISC-II trials, such as the patient
populations (VANQWISH patients had a higher clinical
risk profile), adjuvant therapies (use of glycoprotein IIb/IIIa
inhibitors and low molecular weight heparin in FRISC-II)
and a higher complication rate of revascularization in
VANQWISH.
Based on the results of TACTICS-TIMI-18, it could be
argued that an invasive approach is superior and that risk
stratification by stress testing is not needed. However, this
has been clearly demonstrated only in higher-risk patients.
Centers that prefer risk stratification for low-risk patients or
that lack facilities to support a routine invasive strategy for
patients who are not clearly high-risk (13) should use a risk
stratification protocol similar to that of VANQWISH or
TACTICS-TIMI-18, which includes radionuclide imag-
ing, pharmacologic testing and more sensitive stress ECG
criteria for ischemia, as advocated by ACC/AHA guidelines
(10).
Conclusions. Our results of coronary angiographic find-
ings in VANQWISH suggest that the more restrictive
stress test criteria used in FRISC-II may have failed to
identify a substantial number of patients with surgical CAD
who might have benefited from early cardiac catheterization
and revascularization. Our study supports the need for
appropriate risk-stratification techniques should physicians
choose to perform provocative testing in subgroups at low
risk based on clinical characteristics or among patients who
are not clearly high-risk and who present to medical centers
without on-site catheterization facilities.
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